Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boucek

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Cardiology in the Young|June 7, 2005
Late replacement of the pulmonary valve: when and what type of valve?James A Quintessenza, Jeffrey P Jacobs, Paul J Chai, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivoA Steele, O Y Jones, F Gok, et al.
The Journal of Clinical Investigation|April 1, 1993
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit modelD A Dodd, J B Atkinson, R D Olson, et al.
Cardiology in the Young|June 18, 2019
Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantationPatrick D Evers, Neal Jorgensen, Borah Hong, et al.
Journal of the American College of Cardiology|November 15, 1989
Absence of left ventricular volume loading in infants with coarctation of the aorta and a large ventricular septal defectT P Graham, J Burger, R J Boucek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.
The American Journal of Cardiology|January 15, 1983
Radionuclide stroke count ratios for assessment of right and left ventricular volume overload in childrenM D Parrish, T P Graham, M L Born, et al.
Clinical Transplantation|December 27, 2017
A tale of two cases of pulmonary arteriovenous malformation: How they fared after cardiac transplantationBethany L Wisotzkey, Dari L Magyar, Thomas K Jones, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1985
Pathophysiology of chronic cyanosis in a canine model. Functional and metabolic response to global ischemiaF M Lupinetti, T H Wareing, C B Huddleston, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Cardiology in the Young|June 7, 2005
Late replacement of the pulmonary valve: when and what type of valve?James A Quintessenza, Jeffrey P Jacobs, Paul J Chai, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivoA Steele, O Y Jones, F Gok, et al.
The Journal of Clinical Investigation|April 1, 1993
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit modelD A Dodd, J B Atkinson, R D Olson, et al.
Cardiology in the Young|June 18, 2019
Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantationPatrick D Evers, Neal Jorgensen, Borah Hong, et al.
Journal of the American College of Cardiology|November 15, 1989
Absence of left ventricular volume loading in infants with coarctation of the aorta and a large ventricular septal defectT P Graham, J Burger, R J Boucek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.
The American Journal of Cardiology|January 15, 1983
Radionuclide stroke count ratios for assessment of right and left ventricular volume overload in childrenM D Parrish, T P Graham, M L Born, et al.
Clinical Transplantation|December 27, 2017
A tale of two cases of pulmonary arteriovenous malformation: How they fared after cardiac transplantationBethany L Wisotzkey, Dari L Magyar, Thomas K Jones, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1985
Pathophysiology of chronic cyanosis in a canine model. Functional and metabolic response to global ischemiaF M Lupinetti, T H Wareing, C B Huddleston, et al.
Pageof 18